Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial ; volume:23 ; number:1 ; day:23 ; month:9 ; year:2023 ; pages:1-9 ; date:12.2023
BMC gastroenterology ; 23, Heft 1 (23.9.2023), 1-9, 12.2023
- Urheber
-
Attaran, Fereshte
Emami, Sepideh
Sohrabi, Masoudreza
Malek, Mojtaba
Ajdarkosh, Hossein
Khoonsari, Mahmoodreza
Ismail-Beigi, Faramarz
Khamseh, Mohammad E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-023-02948-4
- URN
-
urn:nbn:de:101:1-2024020512382689182655
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Attaran, Fereshte
- Emami, Sepideh
- Sohrabi, Masoudreza
- Malek, Mojtaba
- Ajdarkosh, Hossein
- Khoonsari, Mahmoodreza
- Ismail-Beigi, Faramarz
- Khamseh, Mohammad E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
Nonalcoholic fatty liver disease and cardiovascular disease risk
Non-alcoholic fatty liver disease
Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease
Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease
Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
Nonalcoholic fatty liver disease and cardiovascular disease risk
Non-alcoholic fatty liver disease
Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease
Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease
Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
Nonalcoholic fatty liver disease and cardiovascular disease risk
Non-alcoholic fatty liver disease
Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease
Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease